Chinese Traditional and Herbal Drugs
|
2025, 56(22): 8258-8272
Clinical medication rules of coronary heart disease with qi deficiency and blood stasis type based on data mining
Full
WANG Hefei1,2, DAI Qi2, LI Weihong2,3, LIU Kedi2,3, LIU Chengzhao2,4, YAO Hong1,2, DING Ziheng1,2, CAO Xinyan1,2, WEI Peifeng1,5, XI Miaomiao2,5
Affiliations
1 College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, China;
2 Xi'an TANK Medicinal Biology Institute, Xi'an 710032, China;
3 College of Life Sciences, Northwest University, Xi'an 710069, China;
4 Institute of Flexible Electronics, Northwestern Polytechnical University, Xi'an 710072, China;
5 National Institute of Drug Clinical Trials, Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712021, China
doi: 10.7501/j.issn.0253-2670.2025.22.017
Outline
Objective To explore the medication rules of traditional Chinese medicines (TCMs) for the clinical treatment of coronary heart disease (CHD) with qi deficiency and blood stasis type based on data mining. Methods Relevant clinical researches were retrieved from China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform, China Science and Technology Journal Database (VIP), China Biology Medicine disc (CBMdisc), PubMed, Web of Science (WOS) databases and the TCMS database was established by screening the literature in accordance with the inclusion and exclusion criteria of this study. Excel 2019 was used to analyze the usage frequency, efficacy categories, properties, flavours, meridians and dosages of all TCMs, and to explore the clinical medication rules. IBM SPSS Statistics 21.0, IBM SPSS Modeler 18.0 and Cytoscape 3.7.2 software were used to conduct association analysison of all TCMs to obtain the core drug pairs and drug combinations. Lantern 5.0 software was used to perform the latent structure model and comprehensive clustering analysis of TCMs with frequency of use ≥ 10 to obtain the core prescriptions, and to infer the concurrent syndromes of disease on this basis. Gephi 0.9.2 software was used to conduct complex network analysis of all TCMs, mainly including K-core hierarchical analysis and community analysis to obtain the core TCMS and new compound formulas. Results A total of 558 literature were finally screened out according to the inclusion and exclusion criteria of this study, which included 89 TCM prescriptions, 197 TCMs, and the cumulative frequency of use was 5 088 times. The statistical results of the frequency of use and efficacy categories of TCMs showed that the top five TCMs in terms of frequency were Huangqi (Astragali Radix), Danshen (Salvia Miltiorrhiza Radix), Chuanxiong (Chuanxiong Rhizoma), Danggui (Angelicae Sinensis Radix), and Chishao (Paeoniae Radix Rubra). The primary efficacy categories were tonic medicines, blood-circulating and stasis-resolving medicines, interior heat-clearing medicines, exterior-releasing medicines, qi-regulating medicines. The results of the distribution of the properties, flavors and meridians of TCMs showed that the medicinal properties were mainly warm, cold and neutral, the medicinal flavors were mainly sweet, pungent and bitter, and the meridians were mainly liver, heart and spleen. The association analysis of 197 TCMs showed that Astragali Radix, Salvia Miltiorrhiza Radix, Chuanxiong Rhizoma, and Angelicae Sinensis Radix were core TCMs. The top three medicine combinations in terms of association intensity were Salvia Miltiorrhiza Radix-Astragali Radix, Chuanxiong Rhizoma-Astragali Radix, and Angelicae Sinensis Radix-Astragali Radix. The analysis of the latent structure model obtained 15 hidden variables, 30 hidden categories, five comprehensive clustering models, and eight core prescriptions. According to the prescriptions the patients with CHD of qi deficiency and blood stasis type might both have the clinical manifestations of concurrent syndromes of qi stagnation, phlegm dampness, yin deficiency and other syndromes. The K-core hierarchical analysis of the complex network showed tha t46 TCMs such as Astragali Radix, Salvia Miltiorrhiza Radix, Chuanxiong Rhizoma, Angelicae Sinensis Radix, Gancao (Glycyrrhizae Radixet Rhizoma), Paeoniae Radix Rubra, Dangshen (Codonopsis Radix), Honghua (Carthami Flos) and other TCMs were the core TCMS. The three core TCMS were obtained by community clustering namely three new compound formulas. Conclusion This study explored the literature in the treatment of CHD of qi deficiency and blood stasis type in the past ten years through data mining, and summarized the medication rules of TCM for the clinical treatment of CHD of qi deficiency and blood stasis type, Which provided standardized medication references and new treatment ideas for the clinical treatment of CHD of qi deficiency and blood stasis type with TCMs.
coronary heart disease
/
qi deficiency and blood stasis
/
data mining
/
association analysis
/
analysis of latent structure model
/
complex network analysis
/
Astragali Radix
/
Salviae Miltiorrhizae Radix et Rhizoma
/
Chuanxiong Rhizoma
/
Angelicae Sinensis Radix
/
Paeoniae Radix Rubra
王鹤霏, 代旗, 李伟红, 刘珂娣, 刘澄曌, 姚宏, 丁子恒, 曹欣妍, 卫培峰, 奚苗苗.
基于数据挖掘研究气虚血瘀型冠心病的临床用药规律.
中草药,
2025
, 56
(22)
: 8258
-8272
.
DOI: 10.7501/j.issn.0253-2670.2025.22.017
WANG Hefei, DAI Qi, LI Weihong, LIU Kedi, LIU Chengzhao, YAO Hong, DING Ziheng, CAO Xinyan, WEI Peifeng, XI Miaomiao.
Clinical medication rules of coronary heart disease with qi deficiency and blood stasis type based on data mining[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(22)
: 8258
-8272
.
DOI: 10.7501/j.issn.0253-2670.2025.22.017
Year 2025 volume 56 Issue 22
51
14
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.22.017
- Receive Date:2025-06-19
- Online Date:2026-11-13